MedPath

TRIMERIS

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:2

Trial Phases

2 Phases

Phase 1:2
Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)โ€ข Click on a phase to view related trials

Phase 1
2 (66.7%)
Phase 2
1 (33.3%)

Study of Enfuvirtide in HIV-Positive Subjects

Phase 1
Completed
Conditions
HIV Infections
AIDS
First Posted Date
2004-07-13
Last Posted Date
2005-06-24
Lead Sponsor
Trimeris
Target Recruit Count
26
Registration Number
NCT00086710
Locations
๐Ÿ‡บ๐Ÿ‡ธ

SFBC, Miami, Florida, United States

A Rollover Study to Provide Chronic T-1249 to Patients Who Completed Study T1249-102

Phase 1
Conditions
HIV Infections
First Posted Date
2002-10-30
Last Posted Date
2005-06-24
Lead Sponsor
Trimeris
Registration Number
NCT00048217
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Trimeris, Durham, North Carolina, United States

A Study of T-20 in HIV-Positive Adults

Phase 2
Completed
Conditions
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2005-06-24
Lead Sponsor
Trimeris
Target Recruit Count
78
Registration Number
NCT00002228
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Univ of Alabama at Birmingham / 1917 AIDS O/P Cln, Birmingham, Alabama, United States

๐Ÿ‡บ๐Ÿ‡ธ

UCLA School of Medicine / Ctr for Research and Education, Los Angeles, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

San Francisco Gen Hosp, San Francisco, California, United States

and more 8 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

ยฉ 2025 MedPath, Inc. All rights reserved.